Antibiotic Misuse: The Reality of India

Antibiotics are widely regarded as one of the most significant advances in modern medicine. Yet in India and globally, the use of this life-saving invention is slipping out of our control. The country is now one of the world’s largest consumers of antibiotics, and this high usage has created an environment in which antimicrobial resistance (AMR) can easily emerge and spread.

When people talk about antibiotic misuse, they might imagine irresponsible self-medication. But the Indian crisis is deeper than individual behaviour. It is shaped by systemic gaps: overcrowded hospitals, limited diagnostic capacity, supply shortages in public clinics, long travel distances for rural populations, and a large-scale dependence on empirical treatment because rapid diagnostic tests rarely reach the last mile.

Conditions That Enable Antimicrobial Resistance

AMR develops when bacteria evolve after repeated exposure to antibiotics, especially when the drug is unnecessary, at a sub-therapeutic dose, or if taken for fewer days than the suggested duration. In India, all three conditions are extremely common.

1. Easy access to antibiotics

Some antibiotics, including carbapenems, fluroquinolones, and some cephalosporins are classified as Schedule H1 drugs, meaning they can be sold only under a prescription. Yet, enforcement of this rule can be inconsistent, especially in settings where demand is high but access to timely medical care is limited.

2. High infectious disease burden

India still continues to battle tuberculosis, gastrointestinal bugs, dengue, typhoid, neonatal infections, and other respiratory illnesses simultaneously. This leads to high empirical antibiotic use, many times before any diagnostic confirmation.

3. Delayed or limited diagnostics

When culture results take 48 to 72 hours, but the patient is severely ill, broad-spectrum antibiotics are started immediately. And without molecular diagnostics that are affordable and deployable at scale, this cycle of possibly unnecessary antibiotic use continues.

4. Agricultural and environmental drivers

India’s AMR challenge is not restricted to hospitals. Antibiotics used in poultry, aquaculture, and crop protection enter wastewater and soil, and this creates reservoirs of resistant genes.

Human Stories Inside the Numbers

Think about the common experience of a young adult with a recurring fever and sore throat. First, a chemist dispenses a broad-spectrum antibiotic. When the symptoms improve only slightly, the patient tries another pharmacy, or a second round of antibiotics. Only when it becomes severe do they visit a hospital, where doctors might discover an infection that is resistant to first-line drugs.

So, what looks like misuse is very likely desperation within a constrained health system. In some Tier 2 and Tier 3 towns, visiting a doctor means long travel, long queues, and for some, a day’s lost wages. Chemists become the first point of care, not because people are careless, but because the system is strained.

India’s Battle with Drug-Resistant Pathogens

India is home to some of the world’s highest rates of resistant pathogens, like carbapenem-resistant Klebsiella pneumoniae, fluoroquinolone-resistant Salmonella typhi, multidrug-resistant TB, and extended-spectrum beta-lactamase (ESBL)-producing E. coli in community settings.

The Path Forward Must Be Diagnostics-First

Banning OTC antibiotics is not enough.

What India needs is:

• Affordable rapid tests to differentiate viral vs bacterial infections
• Genomic AMR surveillance
• Public awareness focused not on blame, but on access and solutions.
• Stronger stewardship in both healthcare and agriculture.

That said, diagnostics alone can never replace sound clinical judgement. Laboratory findings, including genomic resistance markers, still need careful clinical correlation and should inform, but not dictate, treatment decisions.

Addressing AMR in India will require policies that evolve as quickly as bacteria do, supported by diagnostics, clinical judgement, and system-wide antimicrobial stewardship working together.